Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Treatment of Neuropathic Pain and Functional Limitations Associated With Multiple Sclerosis Using an MRI-Compatible Spinal Cord Stimulator: A Case Report With Two Year Follow-Up and Literature Review.
Occupational Exposure and Risk of Central Nervous System Demyelination.
[Case report: a case of chronic inflammatory demyelinating polyneuropathy (CIDP) exacerbated by influenza vaccination].
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity.
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Simvastatin regulates oligodendroglial process dynamics and survival.
Picornavirus infection leading to immunosuppression.
A bird's-eye view of T cells during natalizumab therapy.
Effect of virtual reality-based balance training in multiple sclerosis.
[Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate].
Tysabri (natalizumab)
Galanin Transgenic Mice with Elevated Circulating Galanin Levels Alleviate Demyelination in a Cuprizone-Induced MS Mouse Model.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Construct Validity, Responsiveness, and Interpretation.
[Factorial structure of the dysexecutive questionnaire in a sample of the Spanish population with acquired brain injury and memory deficit complaints].
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
Deafness in Patients with Multiple Sclerosis.
Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system.
[CHANGES IN THE QUALITATIVE AND QUANTITATIVE COMPOSITION OF GUT MICROBIOTA IN RATS DURING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS].
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study.
Urinary tract infection in multiple sclerosis: a practical algorithm for a common problem.
Prognostic indicators for long-term disability in multiple sclerosis patients.

Pages